SMTL ID : 6gga.2 (1 other biounit)

p53 cancer mutant Y220C in complex with small-molecule stabilizer PK9284

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.55 Å

Oligo State

monomer

Ligands

1 x EY2: (7-bromanyl-9-ethyl-carbazol-3-yl)methyl-methyl-azanium(Non-covalent)

EY2.1: 12 residues within 4Å: Chain A: L.52, W.53, V.54, T.57, P.58, C.127, E.128, P.129, P.130, D.135, C.136, T.137 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:L.52, A:V.54, A:V.54, A:T.57, A:P.129, A:P.130 Hydrogen bonds: A:D.135

1 x ZN: ZINC ION(Non-covalent)

ZN.2: 4 residues within 4Å: Chain A: C.83, H.86, C.145, C.149 4 PLIP interactions: 4 interactions with chain A Metal complexes: A:C.83, A:H.86, A:C.145, A:C.149

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Bauer, M.R. et al., A structure-guided molecular chaperone approach for restoring the transcriptional activity of the p53 cancer mutant Y220C. Future Med Chem (2019)

Release Date

2019-05-22

Peptides

Cellular tumor antigen p53: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Cellular tumor antigen p53

Related Entries With Identical Sequence